Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 202992

Expand all

AUBAGIO (TERIFLUNOMIDE)
7MG Marketing Status: Prescription

Active Ingredient: TERIFLUNOMIDE
Proprietary Name: AUBAGIO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N202992
Product Number: 001
Approval Date: Sep 12, 2012
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

AUBAGIO (TERIFLUNOMIDE)
14MG Marketing Status: Prescription

Active Ingredient: TERIFLUNOMIDE
Proprietary Name: AUBAGIO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 14MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N202992
Product Number: 002
Approval Date: Sep 12, 2012
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English